Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,990 stories, page 639 of 750

Advanced search

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

FDA Approves Viridian's Lumvoa for Thyroid Eye Disease (TED)

Eyewire+Original source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In. -- Barrons.com

MoomooOriginal source

🇺🇰Jun 27Regulatorygov.ukTier 1 · Regulatory source

Pioneering projects to transform obesity care, backed by £85 million from government and industry

A dozen cutting-edge projects will benefit thousands of patients battling obesity across the UK.

UK Department of Health and Social CareOriginal source

🌍Jun 27discoverynews.google.comTier 2 · Trade media

FDA approves Viridian eye drug, stoking competition with Amgen’s Tepezza

Endpoints NewsOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Medpace (MEDP) Has a Backlog-and-Execution Engine Bigger Than a Biotech-Funding Scare

AlphaStreetOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Argentina joins Chinese coronavirus vaccine trial

SONNA | Somali National News AgencyOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

The Manila TimesOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Viridian Therapeutics announced that its innovative drug Lumvoa™ (generic name: veligrotug-vvze) has been approved by the U.S. Food and Drug Administration (FDA) and officially launched for the treatment of Thyroid Eye Disease (TED).

BitgetOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Sunhawk Vision Biotech, Inc. – TPEX:7759

TradingViewOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Is Axsome Therapeutics (AXSM) Using Solriamfetol’s Phase 3 ADHD Trial To Redefine Its CNS Strategy?

simplywall.stOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

Business WireOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

More Than 900,000 Bottles of Heart and Kidney Drugs Recalled: FDA Notice

mb.ntd.comOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Lantheus stock falls after FDA rejects drug application

Investing.comOriginal source

🌍Jun 27Industrymatinasbiopharma.comTier 1 · Company source

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

Matinas BioPharmaOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

MarketWatchOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

FDA Will Reportedly Conclude Abortion Pill Safety Review by September

Focus on the FamilyOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Universe Pharmaceuticals Inc Announces Strategic Acquisition To Expand Pharmaceutical Patent Portfolio

TradingViewOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Swiss pharma at risk of US trade investigation, industry body says

1470 & 100.3 WMBDOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

The Manila TimesOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

AbbVie Inc Stock (ABBV) Closed Up by 3.53% on Jun 26: Facts Behind the Movement

TradingKeyOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Swiss pharmaceutical industry faces potential US trade investigation

Crypto BriefingOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

The Manila TimesOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

The Manila TimesOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

ALXN1840 Phase 3 data back NDA plan for Wilson disease, Monopar (NASDAQ: MNPR)

Stock TitanOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Monopar’s Wilson disease drug shows stronger neurologic gains in Phase 3

Stock TitanOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Universe Pharmaceuticals bets $10.8M on five China patents

Stock TitanOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

GlobeNewswireOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

FDA declines to approve Sobi's gout therapy on concerns over manufacturing

ReutersOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

FDA warns 25 telehealth companies over claims about weight-loss drugs

MSNOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Norwich Loses Appeal Over FDA Delay of Its Generic Xifaxan Drug

Bloomberg Law NewsOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In.

Barron'sOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

WHO issues guideline to curb environmental waste in pharmaceutical manufacturing

RAPS.orgOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

UNCY Stock On Track For Worst Day In About A Year Ahead Of FDA Decision On Lead Drug

Asianet NewsableOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Why Flexibility is the Secret to Modern Biotech Deals

BioPharm InternationalOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Shuts JJ Mahanagar Blood Bank Over Safety Violations

The Times of IndiaOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Weekly Rundown: Definium's psychedelic drug delivers rapid relief in major depression in late-stage study

Drug Discovery NewsOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Report: Lawmakers Say FDA Safety Review of Abortion Pill Could Be Complete by September

breitbart.comOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

The Critical Medicines Act’s Impact on Pharmaceutical Manufacturing and Supply Resilience in Europe

PharmTech.comOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Centanafadine Demonstrates Statistically Significant, Clinically Relevant Improvements in ADHD Symptoms

Pharmacy TimesOriginal source

🌍Jun 27discoverynews.google.comTier 2 · Trade media

Free Workshop – Measuring and Characterising Pharma

Pharmaceutical TechnologyOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Prescription Pulse

PoliticoOriginal source

🌍Jun 27Mediavariational.aiTier 2 · Direct publisher

Variational AI featured in AWS’s “Canada’s AI Innovators” series

Variational AIOriginal source

🇺🇸Jun 27Devicesorthopediatrics.comTier 1 · Company source

OSSIOfiber® Suture Anchors

OrthoPediatricsOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Anna Berkenblit: Highlights from the ASCO Annual Meeting and Beyond

OncodailyOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Tirzepatide and Emerging OSA Pharmacotherapy Expand the Treatment Toolkit, With Ashesha Mechineni, MD

Patient Care OnlineOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

FDA Maharashtra Suspends Operations Of Two Blood Centres Over Serious Regulatory Violations

Free Press JournalOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Why effectiveness is the ultimate measure of trust

The Manila TimesOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Swiss pharma at risk of US trade investigation, industry body says

The Mighty 790 KFGOOriginal source

🌍Jun 27discoverynews.google.comTier 2 · Trade media

Pharmaceutical Technology

Pharmaceutical TechnologyOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Policy Watch: HHS moves to keep more drug trials in the US

C&ENOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

NEW: 5th Circuit Grants Sept. Hearing in Mail-Order Abortion Drug Case as Groups Urge Blanche to Settle

SBA Pro-Life AmericaOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA issues sweeping crackdown on food safety violations across eateries

Mid-dayOriginal source

🌍Jun 27discoverynews.google.comTier 3 · Aggregated media

New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD

Psychiatric TimesOriginal source

🌍Jun 27discoverynews.google.comTier 2 · Trade media

At BIO, tension over China biotech deal regulation looms

BioPharma DiveOriginal source

🌍Jun 26discoverynews.google.comTier 3 · Aggregated media

Generic Enzalutamide Receives Tentative FDA Approval in Prostate Cancer

CancerNetworkOriginal source

🌍Jun 26discoverynews.google.comTier 3 · Aggregated media

UBS raises Incyte stock price target to $113 on biotech recovery

Investing.comOriginal source

🌍Jun 26discoverynews.google.comTier 3 · Aggregated media

Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value

PharmTech.comOriginal source

🌍Jun 26discoverynews.google.comTier 3 · Aggregated media

Adragos Pharma Kawagoe, Towa Pharmaceutical Ink Strategic Supply Pact

Contract PharmaOriginal source

🌍Jun 26discoverynews.google.comTier 3 · Aggregated media

China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)

TradingViewOriginal source

🌍Jun 26Regulatoryinfarma.plTier 1 · Regulatory source

Stanowisko do projektu ustawy o zmianie ustawy o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych oraz niektórych innych ustaw

INFARMA PolandOriginal source